These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 993121)

  • 1. Microbial transformation of antibiotics II. Additional transformation products of maridomycin III.
    Shibata M; Uyeda M; Mori S
    J Antibiot (Tokyo); 1976 Aug; 29(8):824-8. PubMed ID: 993121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial transformation of antibiotics. III. Reacylation of 4"-depropionyl maridomycin III into maridomycin V (maridomycin K) by Streptomyces sp. strain no. K-342.
    Uyeda M; Mori S; Morita M; Ogata T; Mori M; Shibata M
    J Antibiot (Tokyo); 1977 Dec; 30(12):1130-1. PubMed ID: 599088
    [No Abstract]   [Full Text] [Related]  

  • 3. I. Isolation and characterization of the transformation products of maridomycin III.
    Shibata M; Uyeda M; Mori S
    J Antibiot (Tokyo); 1975 Jun; 28(6):434-41. PubMed ID: 1150539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physico-chemical properties of new acyl derivatives of tylosin produced by microbial transformation.
    Okamoto R; Fukumoto T; Nomura H; Kiyoshima K; Nakamura K; Takamatsu A; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1300-8. PubMed ID: 7251471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial transformation of maridomycin III by Serratia marcescens.
    Uyeda M; Kubota K; Miyamura S; Shibata M
    J Antibiot (Tokyo); 1983 Dec; 36(12):1722-8. PubMed ID: 6363373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enzymatic interconversion between midecamycin A1 and A3.
    Matsuhashi Y; Ogawa H; Nagaoka K
    J Antibiot (Tokyo); 1979 Jul; 32(7):777-9. PubMed ID: 541276
    [No Abstract]   [Full Text] [Related]  

  • 7. Deltamycins, new macrolide antibiotics. III. Chemical structures.
    Shimauchi Y; Kubo K; Osumi K; Okamura K; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Sep; 32(9):878-83. PubMed ID: 511779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioconversion of leucomycins and its regulation by butyrate in a producing strain.
    Omura S; Miyazawa J; Takeshima H; Kitao C; Atsumi K
    J Antibiot (Tokyo); 1976 Oct; 29(10):1131-3. PubMed ID: 994332
    [No Abstract]   [Full Text] [Related]  

  • 9. Deepoxidation of 16-membered epoxyenone macrolide antibiotics. I. Microbial deepoxidation and subsequent isomerization of deltamycins A1, A2, A3, A4 (carbomycin A) and X.
    Fukagawa Y; Mutoh Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1984 Feb; 37(2):118-26. PubMed ID: 6706847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deltamycins, new macrolide antibiotics. II. Isolation and physicochemical properties.
    Shimauchi Y; Kubo K; Osumi K; Okamura K; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1978 Apr; 31(4):270-5. PubMed ID: 659324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of rosamicin antibiotic into 10,11-dihydrorosamicin with enhanced in vitro antibacterial activity against MRSA.
    Huong NL; Hoang NH; Shrestha A; Sohng JK; Yoon YJ; Park JW
    J Microbiol Biotechnol; 2014 Jan; 24(1):44-7. PubMed ID: 24064918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maridomycin, a new macrolide antibiotic. XI. The structures of maridomycin components.
    Muroi M; Izawa M; Kishi T
    Chem Pharm Bull (Tokyo); 1976 Mar; 24(3):463-78. PubMed ID: 1021252
    [No Abstract]   [Full Text] [Related]  

  • 13. Maridomycin, a new macrolide antibiotic. VII. Incorporation of labeled precursors into maridomycin and preparation of 14C-labeled 9-propionylmaridomycin.
    Ono H; Harada S; Kishi T
    J Antibiot (Tokyo); 1974 Jun; 27(6):442-8. PubMed ID: 4853096
    [No Abstract]   [Full Text] [Related]  

  • 14. Maridomycin, a new macrolide antibiotic. XII. A simple quantitative analysis of 9-propionylmaridomycin components.
    Kunishige N; Kawamura K; Muroi M; Kishi T
    Chem Pharm Bull (Tokyo); 1975 Dec; 23(12):3075-80. PubMed ID: 1218448
    [No Abstract]   [Full Text] [Related]  

  • 15. Maridomycin, a new macrolide antibiotic. X. The structure of maridomycin II.
    Muroi M; Izawa M; Kishi T
    Chem Pharm Bull (Tokyo); 1976 Mar; 24(3):450-62. PubMed ID: 1021251
    [No Abstract]   [Full Text] [Related]  

  • 16. The microbial transformation of tylosin by the spiramycin-producing strain, Streptomyces ambofaciens KA-1028.
    Omura S; Kitao C; Sadakane N
    J Antibiot (Tokyo); 1980 Aug; 33(8):911-2. PubMed ID: 7429995
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of the bioconversion of leucomycins by glucose in a producing strain.
    Omura S; Miyazawa J; Takeshima H; Kitao C; Aizawa M
    J Antibiot (Tokyo); 1977 Feb; 30(2):192-3. PubMed ID: 849921
    [No Abstract]   [Full Text] [Related]  

  • 18. Analytical studies of maridomycin. I. High-performance liquid chromatography of marido-mycins and some other macrolide antibiotics.
    Kondo K
    J Chromatogr; 1979 Feb; 169():329-36. PubMed ID: 536423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deltamycins, new macrolide antibiotics. I. Producing organism and fermentation.
    Shimauchi Y; Okamura K; Koki A; Hasegawa M; Date M; Fukagawa Y; Kouno K; Ishikura T
    J Antibiot (Tokyo); 1978 Apr; 31(4):261-9. PubMed ID: 659323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial transformation of leucomycin A5.
    Singh K; Rakhit S
    J Antibiot (Tokyo); 1979 Jan; 32(1):78-80. PubMed ID: 761994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.